...
机译:E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation
Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and;
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital,Zhejiang;
Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang ProvinceDepartment of Pathology and Molecular Medicine, Faculty of Health Sciences,McMaster UniversityInstitute of Organ Transplantation, Zhejiang UniversityKey Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering ResearchZJU‐Hangzhou Global Scientific and Technological Innovation CenterZhejaing University,School of Medicine;
drug resistance; E2F7; hepatocellular carcinoma; mTOR inhibitor;